(Q33181522)

23 July 2017

title

Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses (English)

1 reference

23 July 2017

1 reference

F Namour

1

1 reference

23 July 2017

D H Wessels

2

1 reference

23 July 2017

M H Pascual

3

1 reference

23 July 2017

D Reynolds

4

1 reference

23 July 2017

E Sultan

5

1 reference

23 July 2017

B Lenfant

6

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Antimicrobial Agents and Chemotherapy

23 July 2017

published in

1 reference

23 July 2017

volume

45

1 reference

23 July 2017

issue

1

1 reference

23 July 2017

page(s)

170-175

1 reference

Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae

23 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

Antipneumococcal Activities of a Ketolide (HMR 3647), a Streptogramin (Quinupristin-Dalfopristin), a Macrolide (Erythromycin), and a Lincosamide (Clindamycin)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90256

Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11120961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In-vitro activity of ketolides against mycoplasmas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11120961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.45.1.170-175.2001

1 reference

23 July 2017

1 reference

23 July 2017

1 reference